Zhien Zhou
Overview
Explore the profile of Zhien Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rusu M, Jahanandish H, Vesal S, Li C, Bhattacharya I, Venkataraman R, et al.
Eur Urol Oncol
. 2025 Jan;
PMID: 39880746
Background And Objective: To assess whether conventional brightness-mode (B-mode) transrectal ultrasound images of the prostate reveal clinically significant cancers with the help of artificial intelligence methods. Methods: This study included...
2.
Wang T, Liu X, Li H, Liu Y, Liu X, He D, et al.
J Colloid Interface Sci
. 2024 Oct;
679(Pt B):254-262.
PMID: 39454257
Relying on surpassing high theoretical capacity (3,865 mAh/g) and the lowest relative electrode potential (0 V vs. metallic Li), lithium metal batteries (LMBs) have been regarded as the "holy grail"...
3.
Zhou Y, Ji Z, Yan W, Zhou Z, Li H, Xiao Y
Oncol Rep
. 2024 Sep;
52(5).
PMID: 39301643
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell invasion assay data shown in Fig. 3B on...
4.
Chen J, Wang Z, Zhou Y, Zhou Z, Yan W
Obes Res Clin Pract
. 2024 Sep;
18(4):293-300.
PMID: 39232915
Purpose: This study aims to investigate the association between Body Mass Index (BMI) and sex hormone levels utilizing a cross-sectional study design alongside Mendelian randomization (MR) analysis. Materials And Methods:...
5.
Feng T, Liang Z, Xiao Y, Pan B, Zhou Y, Ma C, et al.
Cancer Med
. 2024 Jun;
13(11):e7341.
PMID: 38845479
Background: This study evaluates the efficacy of a nomogram for predicting the pathology upgrade of apical prostate cancer (PCa). Methods: A total of 754 eligible patients were diagnosed with apical...
6.
Zhou Z, Zhou Y, Yan W, Feng T, Liang Z
Oncol Lett
. 2024 May;
28(1):319.
PMID: 38807677
Leuprorelin acetate microspheres, a common gonadotropin-releasing hormone agonist, have certain clinical benefits for prostate cancer (PCa). The present study aimed to compare the efficacy and safety of generic and branded...
7.
Zhang J, Li J, Hou Y, Lin Y, Zhao H, Shi Y, et al.
Cell
. 2024 May;
187(13):3409-3426.e24.
PMID: 38744281
Alterations in extracellular matrix (ECM) architecture and stiffness represent hallmarks of cancer. Whether the biomechanical property of ECM impacts the functionality of tumor-reactive CD8 T cells remains largely unknown. Here,...
8.
Zuo Y, Liang Z, Yang S, Pan B, Cheng S, Zhou Z, et al.
J Endocr Soc
. 2024 Mar;
8(5):bvae041.
PMID: 38533349
Objective: Adrenal hemangioma (AH) is a rare, benign adrenal tumor often detected incidentally by imaging. This retrospective study aimed to investigate the clinical characteristics of AH, including clinical and diagnostic...
9.
Mai Z, Yuan R, Yan W, Zhou Y, Zhou Z, Ren M, et al.
Transl Cancer Res
. 2024 Mar;
13(2):651-660.
PMID: 38482427
Background: Without a pseudocapsule, prostate cancer is invasive in volume growth and has some regularity in spatial distribution. Our study aims to explore the specific origin location, invasive characteristics, and...
10.
Liang Z, Feng T, Zhou Y, Yang Y, Sun Y, Zhou Z, et al.
Am J Cancer Res
. 2024 Feb;
14(1):73-85.
PMID: 38323293
This study aimed to construct nomograms for predicting the likelihood of clinically significant prostate cancer (csPCa) in patients with lesions rated as Prostate Imaging Reporting and Data System (PI-RADS) 3...